OXURION (EBR:OXUR) | Finanzwire

BRIEF

published on 07/04/2025 at 18:05, 6 months 26 days ago

Oxurion Boosts Voting Rights with Recent Capital Increase

Shares Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/04/2025 at 18:00, 6 months 26 days ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC's 4 convertible bonds conversion led to a EUR 100,000 capital increase for Oxurion, aiding in focusing on vision preservation for elderly. Updated share capital and voting rights revealed

Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion Vision Preservation
BRIEF

published on 07/03/2025 at 18:05, 6 months 27 days ago

Oxurion Reports Shareholding Changes by Atlas Special Opportunities

Transparency Shareholding Legislation Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/03/2025 at 18:00, 6 months 27 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications, crossing under thresholds due to selling of voting securities. Company combines therapeutic innovation with clinical research technologies

Clinical Research Oxurion NV Therapeutic Innovation Transparency Notifications Voting Securities
BRIEF

published on 06/30/2025 at 18:05, 7 months ago

Oxurion Reports Transparency Notification from Atlas Special Opportunities

Transparency Notification Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 06/30/2025 at 18:00, 7 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC as it crosses under 10% shareholding threshold by selling voting securities. Company focused on therapeutic innovation and clinical research technologies

Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
BRIEF

published on 06/25/2025 at 18:05, 7 months 5 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 06/25/2025 at 18:00, 7 months 5 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a decrease in shareholding below the threshold. The biopharmaceutical company is focused on therapeutic innovation and clinical research technologies

Technology Clinical Research Transparency Notification Biopharmaceutical Oxurion NV
BRIEF

published on 06/19/2025 at 08:35, 7 months 12 days ago

Oxurion to Acquire Preclinical Microbiology CRO in Toulouse

Acquisition Diversification Toulouse Oxurion Microbiology CRO
PRESS RELEASE

published on 06/19/2025 at 08:30, 7 months 12 days ago

Oxurion signs a letter of intent for the planned acquisition of a preclinical microbiology CRO to diversify and strengthen its presence in the Toulouse region
Oxurion NV announces LOI to acquire 70% share capital of preclinical microbiology services company. Economic details of the transaction and growth projections disclosed

Acquisition Transaction Details Growth Projections Oxurion NV Preclinical Microbiology

Published on 01/31/2026 at 03:15, 8 hours 38 minutes ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 9 hours 33 minutes ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 10 hours 13 minutes ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 11 hours 53 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 12 hours 53 minutes ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 02:45, 9 hours 8 minutes ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 13 hours 53 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 15 hours 43 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 15 hours 43 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 15 hours 46 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches

View all EQS

Published on 01/30/2026 at 17:45, 18 hours 8 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 1 day 3 hours ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 17 hours ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 18 hours ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 18 hours ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News